Alucent Biomedical
Manufacturing · Utah, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
675 S Arapeen Dr Ste 102, Salt Lake City...Phone Number
(385) 722-2300Website
www.alucentmedical.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Alucent Biomedical
Alucent Biomedical is a privately held company dedicated to developing and commercializing its breakthrough Natural Vascular Scaffolding (AlucentNVS) technology for the treatment of vascular disease. AlucentNVS is designed to use photoactivated protein linking of the vessel's native structural proteins to open vessels and keep them open - without the use of permanent implants. Alucent Biomedical was founded by the Avera Research Institute, part of the multistate Avera Health System, in 2017.Explore more
Alucent Biomedical Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Alucent Biomedical your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Alucent Biomedical, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Alucent Biomedical has new funding data
Check out if Alucent Biomedical is spiking on competitors!
Check if Alucent Biomedical has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Alucent Biomedical recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Alucent Biomedical had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Alucent Biomedical launches new products
Congratulate Masked Content for being promoted to Masked Content at Alucent Biomedical
Recommended Actions
Find VP level buyers at Alucent Biomedical
Find 3 more new buyers
Compare Similar Companies to Alucent Biomedical
Compare insights from companies similar to Alucent Biomedical, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Alucent Biomedical is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Alucent Biomedical is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Alucent Biomedical.
Alucent Biomedical financials insights
Gather financial insights about Alucent Biomedical, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Series B
$35M
Alucent Biomedical Tech Stack
A closer look at the technologies used by Alucent Biomedical
Alucent Biomedical News & Media
Alucent Biomedical Wins FDA Approval for U.S. Clinical Study
SALT LAKE CITY--(BUSINESS WIRE)--Alucent Biomedical Inc. today announced that the U.S. Food & Drug Administration granted an Investigational Device Exemption (IDE) for a U.S. clinical study of AlucentNVS, a unique light-activated, drug-coated balloon catheter technology. AlucentNVS combines an intravascular device with a photochemical process to link structural proteins in the wall of a blood vessel to control vascular remodeling. The intervention is designed to promote patency of the vesseAlucent Biomedical Announces First Patient Enrolled in First In Human Natural Vascular Scaffolding Clinical Trial
SALT LAKE CITY--(BUSINESS WIRE)--The first patient in the ACTIVATE II study of AlucentNVS for treating PAD was enrolled by Dr. Chris Delaney at Flinders Medical Centre in Adelaide.Stanford Surgeon Venita Chandra Joins Alucent Biomedical Scientific Advisory Board as Company Enters Arteriovenous Fistula Market
SALT LAKE CITY--(BUSINESS WIRE)--Alucent Biomedical has named Venita Chandra, M.D., to its scientific advisory board as it seeks to adapt its Alucent NVS technology for a new use.Alucent Biomedical Announces $35 Million Series B Financing Led by a Multinational Strategic Investor
SALT LAKE CITY--(BUSINESS WIRE)-- #AlucentNVS--Alucent Biomedical closes $35 million Series B financing round led by a large multinational strategic investor and joined by Fresenius Medical.
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Alucent Biomedical
Sign Up For FreeTo access detailed company insights
Alucent Biomedical is a privately held company dedicated to developing and commercializing its breakthrough Natural Vascular Scaffolding (AlucentNVS) technology for the treatment of vascular disease. AlucentNVS is designed to use photoactivated protein linking of the vessel's native structural proteins to open vessels and keep them open - without t... Read More
